MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (€œBioSyent€, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton &...
MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent or the Company, TSX Venture: RX) announces that Mr. Ren© Goehrum, President and CEO of BioSyent, will be...
MISSISSAUGA, Ontario , Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent, the Company, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (TSX-V) has accepted the...
MISSISSAUGA, Ontario, Nov. 15, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (BioSyent, the Company, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (œBioSyent, œthe Company, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
MISSISSAUGA, Ontario, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (œBioSyent, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has commenced the first...
MISSISSAUGA, Ontario, July 06, 2023 (GLOBE NEWSWIRE) -- BioSyent Pharma Inc. (€œBioSyent Pharma€), a subsidiary of BioSyent Inc. (€œBioSyent€, €œthe Company€, TSX Venture: RX), is attending the...
MISSISSAUGA, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (œBioSyent, œthe Company, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has received...
MISSISSAUGA, Ontario, May 26, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2023. Key highlights...